^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
AUTO4
i
Other names: chimeric antigen receptor T-cell therapy, dominant negative SHP2 protein engineered CAR T-cells, engineered T-cell immunotherapeutics, AUTO4, anti-TRBC1 CAR T-cells, AUTO 4
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Autolus
Drug class:
TRBC1-targeted CAR-T immunotherapy
›
